Childress Capital Advisors LLC Purchases Shares of 12,000 iShares U.S. Pharmaceuticals ETF $IHE

Childress Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,000 shares of the company’s stock, valued at approximately $1,018,000.

Other institutional investors have also recently made changes to their positions in the company. Mather Group LLC. acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at about $38,000. Assetmark Inc. raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 203.9% during the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after purchasing an additional 312 shares during the period. Ameriflex Group Inc. raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock valued at $42,000 after purchasing an additional 291 shares during the period. National Bank of Canada FI raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after purchasing an additional 175 shares during the period. Finally, CX Institutional raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 2,665.5% during the third quarter. CX Institutional now owns 802 shares of the company’s stock valued at $58,000 after purchasing an additional 773 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $87.36 on Thursday. iShares U.S. Pharmaceuticals ETF has a 52 week low of $61.64 and a 52 week high of $92.29. The stock has a 50 day moving average price of $88.08 and a two-hundred day moving average price of $83.80. The stock has a market capitalization of $960.96 million, a PE ratio of 17.75 and a beta of 0.52.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.